We have been representing patients and their family in drug injury lawsuits for the past 16 years and this is our main practice area.
Drug injury legal compensation cases involve personal injury or wrongful death claims filed on behalf of people who, unfortunately, experienced a serious side effect, had an adverse drug reaction, or died from their use of a prescription medication.
Given our many years of experience handling these types of lawsuits we know drug injury cases deserve special attention.
Drug injury claims have a personal aspect which must be appreciated and respected by the attorney handling your case. At our law firm, we do not underestimate nor lose sight of the trust which is being placed in us by clients when they select us to represent them for their lawsuit against the responsible pharmaceutical company.
We will handle your drug injury case not only competently and professionally, but with genuine care and understanding. Any inquiries from our clients are responded to promptly, and telephone calls are always returned without delay.
If you, relatives, or friends need legal advice or legal representation for a personal injury lawsuit or a wrongful death lawsuit involving a drug side effect, the Law Offices of Thomas J. Lamb is here to help.
We encourage you to submit a Drug Injury Law Case Review — it is free, confidential, and there is no obligation. Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible drug injury case. Either way, you will get Mr. Lamb’s impressions — not an intake person, a paralegal, or some other lawyer — about your case based on his many years of experience.
We handle these drug injury cases on a contingency fee basis, meaning that there is no payment for our legal services until we are successful in getting legal compensation for you.
While our office is in Wilmington, North Carolina, we have successfully handled drug injury lawsuits for people all over the United States.
It is important to note that we do not put our clients into large class actions. Rather we favor an individual lawsuit approach, which allows us to give personal attention to each of our clients, from start to finish.
Legal & Medical News: Featured Article
A recent medical journal article discussed the extent to which some popular medications prescribed to treat depression in the Selective Serotonin Reuptake Inhibitors (SSRI) class of drugs, when used by women during pregnancy, are associated with an increased autism risk in children.
The bottom line is that using SSRIs during the second or third trimester of pregnancy is associated with a heightened risk for autism spectrum disorder (ASD) in children. This is according to a JAMA Pediatrics study which is the subject of this article, “Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children”, first published online in December 2015.
The SSRIs class of drugs includes the following:
Effexor (venlafaxine); and,
From the Abstract for the JAMA Pediatrics medical journal article about that study we get this additional information about its findings:
Importance The association between the use of antidepressants during gestation and the risk of autism spectrum disorder (ASD) in children is still controversial. The etiology of ASD remains unclear, although studies have implicated genetic predispositions, environmental risk factors, and maternal depression.
Objective To examine the risk of ASD in children associated with antidepressant use during pregnancy according to trimester of exposure and taking into account maternal depression.
Conclusions and Relevance Use of antidepressants, specifically selective serotonin reuptake inhibitors, during the second and/or third trimester increases the risk of ASD in children, even after considering maternal depression. Further research is needed to specifically assess the risk of ASD associated with antidepressant types and dosages during pregnancy.
We will continue to monitor the apparent link between the use of antidepressant drugs such as Zoloft, Wellbutrin, Prozac, Paxil, and Effexor by women during pregnancy with the new side effect of autism spectrum disorder (ASD) in their children, and report significant developments here.
- Arguments Made To Appeals Court In Fosamax – Femur Fracture Litigation
- Eliquis, Savaysa, And Xarelto Worry Doctors Because No Antidote, Still
- FDA Adds New Ketoacidosis Side Effect Warnings To Invokana Drug Label
- Eliquis Might Be Safer Than Xarelto, But Neither Has Approved Antidote
- Zofran MDL Pending In Massachusetts With Judge Dennis Saylor Presiding
- Hep C Drugs Viekira Pak And Technivie: FDA Warnings About Liver Injury
- October 2015 Update On Bayer’s YAZ / Yasmin Settlement Program Numbers
- Xarelto / Savaysa / Pradaxa / Eliquis: Effect Of Platelet Inhibitors